Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Unichem Lab Plunges 4%; BSE HEALTHCARE Index Up 0.3%
Wed, 23 Oct 11:1

Unichem Lab Plunges 4%; BSE HEALTHCARE Index Up 0.3%Image source: KanawatTH/www.istockphoto.com

Unichem Lab share price has plunged 4% and is presently trading at Rs 820.5.

Meanwhile, the BSE HEALTHCARE index is at 43,191.5 (up 0.3%).

Among the top losers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (down 1.6%) and GLAND PHARMA (down 1.5%).

GRANULES INDIA (up 3.0%) and SUVEN PHARMACEUTICALS (up 2.6%) are among the top gainers today.

Over the last one year, Unichem Lab has moved up from Rs 422.9 to Rs 820.5, registering a gain of Rs 397.7 (up 94.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 43,191.5, registering a gain of 57.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 216.7%), Glenmark Pharma (up 125.9%) and SUVEN PHARMACEUTICALS (up 125.7%).

Don't Miss: Key Information for Long-term Investors

What About the Benchmark Indices?

The BSE Sensex is at 80,410.7 (up 0.2%).

The top gainers among the BSE Sensex today are Bajaj Finance (up 5.2%) and Bajaj Finserv (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 24,532.8 (up 0.3%). Bajaj Finance and Bajaj Auto are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,410.7, registering a gain of 15,838.8 points (up 24.5%).

Unichem Lab Financial Update...

Unichem Lab net profit grew 1485.5% YoY to Rs 93 million for the quarter ended June 2024, compared to a loss of Rs 7 million a year ago. Net sales rose 5.5% to Rs 4,464 million during the period as against Rs 4,232 million in April-June 2023.

For the year ended March 2024, Unichem Lab reported 65.2% increase in net profit to Rs -705 million compared to net loss of Rs 2,022 million during FY23. Revenue of the company grew 26.9% to Rs 17,049 million during FY24.

The current Price to earnings ratio of Unichem Lab, based on rolling 12 month earnings, stands at -95.4.


Equitymaster requests your view! Post a comment on "Unichem Lab Plunges 4%; BSE HEALTHCARE Index Up 0.3%". Click here!